WSJ: Biotech Generics Battle Heats Up
The Wall Street Journal: Firms Push For Biotech GenericsA battle is heating up over the meaning of a single word in the health overhaul that could mean billions of dollars to the makers of biotechnology drugs (Mundy, 1/26). This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
